The Christ Hospital Heart & Vascular Institute Heart Failure Symposium 2025 (Videos + Audios + PDFs)

Advanced Heart Failure, Mechanical Circulatory Support, Cardiac Transplantation & Emerging Cardiomyopathy Therapies

Overview

The Christ Hospital Heart & Vascular Institute Heart Failure Symposium 2025 is an advanced cardiovascular education program focused on the rapidly evolving field of heart failure management. This symposium provides a comprehensive review of contemporary guideline-directed medical therapy (GDMT), advanced heart failure interventions, mechanical circulatory support (MCS), heart transplantation, and emerging treatment options for complex cardiomyopathies.

Designed for cardiologists, heart failure specialists, advanced practice providers, and cardiovascular clinicians, the program explores the latest evidence-based approaches to managing patients across the full spectrum of heart failure—from chronic ambulatory care to cardiogenic shock and advanced-stage disease.

Special emphasis is placed on emerging device technologies, novel pharmacologic therapies, advanced heart failure pathways, ventricular assist devices (LVADs), ECMO support, total artificial heart development, cardiac amyloidosis, and hypertrophic cardiomyopathy management.

This educational package includes 12 video lectures, 12 audio recordings, 12 subtitle files, and 13 downloadable PDF presentations from leading heart failure experts.

Course Highlights

• 12 Video Lectures (MP4)
• 12 Audio Recordings (MP3)
• 12 Subtitle Files (VTT)
• 13 Downloadable PDF Presentations
• Advanced Heart Failure Management
• Guideline-Directed Medical Therapy (GDMT)
• Mechanical Circulatory Support (MCS)
• LVAD & Heart Transplant Updates
• Cardiac Amyloidosis Treatment
• Hypertrophic Cardiomyopathy Therapies
• ECMO & Impella Management
• Emerging Heart Failure Devices

Learning Objectives

Upon completion of this course, participants will be able to:

• Optimize foundational medical therapies for patients with heart failure.
• Apply contemporary guideline-directed medical therapy (GDMT) strategies.
• Evaluate emerging heart failure technologies and device-based interventions.
• Assess current indications and outcomes for heart transplantation.
• Review advances in left ventricular assist device (LVAD) technology.
• Integrate new therapies for cardiac amyloidosis and hypertrophic cardiomyopathy.
• Utilize myosin inhibitors in appropriate patient populations.
• Manage acute heart failure and cardiogenic shock using temporary mechanical support.
• Understand the role of ECMO and Impella in advanced cardiovascular care.
• Explore future innovations including total artificial heart technologies.

Major Topics Covered

Guideline-Directed Medical Therapy (GDMT)

The symposium begins with a review of contemporary evidence-based pharmacologic management for heart failure.

Topics Include

• HFrEF treatment optimization
• Quadruple therapy implementation
• SGLT2 inhibitors
• ARNI therapy
• Beta-blockers
• Mineralocorticoid receptor antagonists

Faculty discuss strategies to maximize therapeutic benefit while improving patient outcomes.

Advanced Heart Failure Management

A major focus of the course is the care of patients with advanced and refractory heart failure.

Covered Topics

• Stage C and Stage D heart failure
• Disease progression
• Referral criteria
• Advanced therapy evaluation
• Prognostic assessment
• Multidisciplinary care pathways

Participants learn when escalation beyond standard medical therapy becomes necessary.

Mechanical Circulatory Support (MCS)

The symposium provides extensive updates on temporary and durable mechanical support systems.

Topics Include

• Mechanical circulatory support algorithms
• Patient selection
• Device management
• Hemodynamic optimization
• Support escalation strategies
• Clinical outcomes

Faculty review how MCS continues to transform care for critically ill heart failure patients.

Left Ventricular Assist Devices (LVADs)

Dedicated sessions focus on the latest advancements in LVAD technology.

Discussion Areas

• Contemporary LVAD pump design
• Device durability
• Patient selection
• Destination therapy
• Bridge-to-transplant strategies
• Long-term outcomes

Participants review recent innovations aimed at improving survival and quality of life.

Heart Transplantation Updates

The symposium highlights major developments in cardiac transplantation.

Topics Include

• 2025 transplant updates
• Candidate selection
• Organ allocation
• Post-transplant management
• Immunosuppression
• Long-term transplant outcomes

Faculty discuss evolving approaches that continue to improve transplant success rates.

Acute Heart Failure & Cardiogenic Shock

Specialized lectures address management of critically ill patients.

Topics Include

• Cardiogenic shock
• Acute decompensated heart failure
• Hemodynamic monitoring
• Mechanical support strategies
• Escalation pathways
• Critical care management

Participants gain practical insights into managing high-acuity cardiovascular emergencies.

ECMO & Temporary Support Devices

The course reviews contemporary use of temporary circulatory support systems.

Covered Topics

• VA-ECMO
• Temporary ventricular support
• Impella technologies
• Shock management
• Patient stabilization
• Transition strategies

Faculty discuss real-world applications of advanced support technologies.

Emerging Heart Failure Devices

The symposium explores next-generation technologies under investigation.

Topics Include

• Doraya system
• Precardia technology
• WhiteSwell platform
• Device innovation
• Novel decongestion therapies
• Future heart failure solutions

These sessions provide insight into technologies that may shape future clinical practice.

Cardiac Amyloidosis

Recognition and treatment of cardiac amyloidosis receive dedicated attention.

Topics Include

• ATTR amyloidosis
• AL amyloidosis
• Diagnostic strategies
• Imaging approaches
• Disease-modifying therapies
• Long-term management

Faculty review major advances that have dramatically improved outcomes for amyloidosis patients.

Hypertrophic Cardiomyopathy (HCM)

The symposium highlights evolving treatment options for HCM.

Topics Include

• Obstructive HCM
• Non-obstructive HCM
• Risk stratification
• Myosin inhibitor therapy
• Symptom management
• Disease progression

Participants learn how novel therapies are changing management paradigms.

Myosin Inhibitors

Emerging pharmacologic therapies receive special focus.

Discussion Areas

• Cardiac myosin inhibition
• Mechanism of action
• Patient selection
• Clinical trial evidence
• Therapeutic monitoring

Faculty discuss the growing role of these agents in modern cardiomyopathy care.

Future of Artificial Heart Technology

The symposium concludes with discussions on next-generation cardiovascular innovation.

Topics Include

• Total artificial heart development
• BIVACOR technology
• Future MCS platforms
• Advanced circulatory support
• Long-term replacement therapies

Participants gain insight into technologies that may redefine treatment options for end-stage heart failure.

Educational Features

✔ Advanced heart failure update

✔ Guideline-directed therapy optimization

✔ Mechanical circulatory support education

✔ Heart transplantation reviews

✔ LVAD technology updates

✔ Cardiac amyloidosis management

✔ Hypertrophic cardiomyopathy treatment advances

✔ ECMO and Impella education

✔ Emerging device technology discussions

✔ Practical clinical application

Who Should Attend?

This course is ideal for:

• Heart Failure Specialists
• Cardiologists
• Advanced Heart Failure & Transplant Cardiologists
• Interventional Cardiologists
• Critical Care Cardiologists
• Cardiothoracic Surgeons
• Internal Medicine Physicians
• Cardiology Fellows
• Nurse Practitioners
• Physician Assistants
• Cardiovascular Pharmacists
• Advanced Practice Providers

Why This Course Stands Out

✔ Dedicated focus on advanced heart failure management

✔ Comprehensive coverage of mechanical circulatory support

✔ Reviews latest transplant and LVAD developments

✔ Includes emerging device technologies not widely covered elsewhere

✔ Strong emphasis on practical clinical decision-making

✔ Covers amyloidosis and hypertrophic cardiomyopathy updates

✔ Integrates pharmacologic and device-based therapies

✔ Evidence-based and guideline-driven content

✔ Relevant for both specialized heart failure programs and general cardiology practice

✔ Features cutting-edge innovations shaping the future of cardiovascular care

4. Topics

1. Medical Therapies- Forming the Most Effective Base

2. Research Innovations – Doraya, Precardia, WhiteSwell, Vectorius, CVRx

3. LVAD’s – Innovations in Management and Pump Design

4. Heart Transplantation – What’s New in 2025

5. Transcatheter Mitral and Tricuspid Devices – When to Intervene and How

6. Atrial Fibrillation and Heart Failure – General Approach in a Sick Population

7. Amyloidosis – The March of Cool Drugs

8. Hypertrophic Cardiomyopathy – Myosin Inhibitors and Beyond

9. Regenerative Therapies for Heart Failure – Successes and Challenges

10. ECMO – Indications, Exclusions, Management

11. Short-term Support – Impella, RVAD, IABP

12. Future of the Machines – BIVACOR